Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Peter Goldberg, Dipl. Ac., Lic. Ac., AP
Peter Goldberg, the senior program advisor for Alternatives to Opioids and a member of the AWB Board of Directors, is licensed in Massachusetts and Florida. He holds two graduate degrees, one in acupuncture physical medicine and the other in community health administration. Peter has held top administrative positions in the corporate, private and nonprofit sectors, with a focus on organizational development, corporate education and training, and volunteer administration.